Collaboration Projects Sample Clauses

Collaboration Projects. During the term of this agreement, the JCC will consider the following collaborative projects, deter- mined by the parties to be of high priority.
Sample 1Sample 2Sample 3See All (9)
AutoNDA by SimpleDocs
Collaboration Projects. During the Collaboration Period, the parties will meet at the beginning of each year within thirty (30) days after the respective anniversary of the Effective Date and draft a mutually agreed written co-development plan for the respective year outlining potential areas of joint development between PalmSource and Licensee that allow the parties to leverage the specific skill sets offered by each party, with the objective of having at least one active mutually agreed Collaboration Project at any given time during the respective year. It is understood, however, that PalmSource may be obligated to provide notice, and enter into good faith discussions, under the Existing Collaboration Agreement prior to pursuing a particular Collaboration Project with Licensee, and that any proposed Collaboration Projects shall be subject to such obligations.
Sample 1Sample 2Sample 3
Collaboration Projects. During the term of this Agreement, the JCC will consider the following col- laborative projects, determined by the parties to be of high priority.
Sample 1
Collaboration Projects. 11.1 The Professional Network will govern the selection and prioritisation of Collaboration Projects. 11.2 The relevant Collaboration Partners identified pursuant to Clause 5.1.5 shall each negotiate in good faith with a view to agreeing and entering into a Collaboration Project Agreement in relation to the Collaboration Projects. 11.3 A Collaboration Project shall only be delivered in accordance with a biding Collaboration Project Agreement executed by the duly authorities representatives of the Collaborating Partners. 11.4 The Parties shall agree a template Collaboration Project Agreement within 45 Business Days of the date of this Collaboration Agreement.
Sample 1
Collaboration Projects. (a) The Parties contemplate that their collaboration pursuant to this Agreement will be carried out in the following five (5) phases: (i) Pilot Production Model Reliability and Manufacturability Improvement Program; (ii) Pilot Production Line Support Program; (iii) Mass Production Model Reliability and Manufacturability Improvement Program; [*****] [*****]. (b) For each of the phases, the Parties will agree upon and implement one or more collaboration projects in order to meet the objectives of that phase (each such project, a “Collaboration Project”). Before commencing each Collaboration Project, the Parties will mutually agree upon and prepare a written plan and schedule for that Collaboration Project, to be attached to and incorporated by reference into this Agreement (each, a “Collaboration Project Plan”)1 (c) The terms and conditions of each Collaboration Project Plan will supplement the terms and conditions of this Agreement with respect to the applicable Collaboration Project and, to the extent expressly inconsistent with the terms of this Agreement, will control with respect to the applicable Collaboration Project. In the ordinary course, the Parties expect that each Collaboration Project Plan will include the following items, subject to any additions or deletions the Parties’ may determine are appropriate for the particular Collaboration Project: (i) a description of the Collaboration Project, including its objective and scope; 1 The initial Collaboration Project Plans shall include, among other things, (i) the projects already in process [*****], (ii) the joint presentation of the Joby/Toyota partnership, [*****] and (iii) [*****]. (ii) participating Parties and Affiliates; (iii) key milestones and timelines; (iv) allocation of intellectual property rights or licenses, including with respect to any Foreground Intellectual Property and any Jointly Developed Intellectual Property expected to result from such Collaboration Project, to the extent different from the terms of this Agreement; (v) the budget, if any, and a description of how costs and expenses are to be allocated, to the extent different from the terms of this Agreement; (vi) the location where work is to be performed; (vii) the number and type of employees to be deployed and dedicated, and the deployment schedule for such personnel; (viii) the obligations of each Party, including deliverables, if any, that either or both Parties will be responsible for creating and developing; and (ix) ...
Sample 1
Collaboration Projects. Danmarks Bløderforenings årsmøde April 2024, Fredericia WFH congress, Madrid April 21-24th 2024
Sample 1
Collaboration Projects. Each Collaboration Project will involve specific Targets that must be approved by the Steering Committee. If Bracco has selected a Target for the Diagnostic Imaging Field, Dyax may only withhold approval for the Diagnostic Imaging Field if Dyax is prevented by an Existing Agreement from using Dyax Technology. With respect to the Bracco Therapeutics Field, Dyax may only withhold approval if Dyax has a program in the Other Therapeutics Field, or if any third party rights arising from an Existing Agreement limit the use of the Target in the Bracco Therapeutic Field. Once a Target has been identified, it shall be the responsibility of the Steering Committee to determine the details of each Collaboration Project, to cause appropriate intellectual property searches to be conducted with regard to the applicable Targets, and to conduct or cause others to conduct appropriate evaluations to determine the technical and commercial feasibility of each Collaboration Project. During the Research Term, Dyax and Bracco, either together or individually, will seek to -------------------------------------- *Confidential Treatment has been requested for the marked portions. identify Collaboration Leads to the Target. The parties will then continue to use Collaboration Projects to develop, evaluate and advance Collaboration Leads and Licensed Products.
Sample 1
AutoNDA by SimpleDocs
Collaboration Projects. 10.1. The PDP Collaboration shall conduct Collaboration Projects of mutual benefit as determined annually by the Board and implemented by the Scientific Committee. 10.2. Collaboration Projects shall involve training and knowledge exchange for mutual benefit wherever possible amongst the Participants. 10.3. Collaboration Projects may only commence following receipt of approval of the Research Plan for a Collaboration Project by the Co-Chairs of the Scientific Committee. 10.4. Academic Xxxxxx employed in Collaboration Projects may not be published during the performance of the Collaboration Project/Screen or during the Term without prior written consent of the Co-Chairs in accordance with the mechanism for approval of publications under Clause 19 below.
Sample 1
Collaboration Projects. The parties agree to periodically undertake joint Collaboration Projects. Each Collaboration Project must be substantially in the form of the template SOW attached hereto as Exhibit A and signed by both parties.
Sample 1

Related to Collaboration Projects

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!